Rheumatoid Arthritis Savings Tips

Savings Tips for Rheumatoid Arthritis

Get the latest updates on this condition from the GoodRx medical team.

  • New Report Discusses Deaths Related to Actemra

    June 15, 2017

    Back in 2010, Actemra (tocilizumab) was approved by the FDA to treat rheumatoid arthritis (RA), an inflammatory condition affecting joints. At the time, with over 1.5 million Americans suffering from RA, Actemra‘s release was promising for many doctors and patients.

    Actemra is a first-in-class drug, meaning it works in a new and unique way to to treat RA, polyarticular juvenile idiopathic arthritis (PJIA), systemic juvenile idiopathic arthritis (SJIA), and as of this month—giant cell arteritis (GCA). See More

  • New Xeljanz XR Available for Arthritis

    March 23, 2016

    Nearly 52.5 million people in the US have arthritis, according to an estimate from the CDC (Centers for Disease Control and Prevention).

    Rheumatoid arthritis one of the most common types, and a new drug has just been approved to help make treatment easier. A new, extended-release form of Xeljanz (tofacitinib) recently received approval from the FDA to treat moderate to severe rheumatoid arthritis.

    What is Xeljanz XR used for?
    Xeljanz XR is recommended for adult patients with moderately to severely active rheumatoid arthritis—and who have had a poor response to methotrexate, or can no longer tolerate it. See More

  • Five Drugs that Changed Healthcare

    June 03, 2015

    In the last decade, billions of dollars have been spent to develop hundreds of new prescription drugs. While some drugs may not necessarily save lives (a prescription for longer eyelashes, anyone?), a handful of drugs have literally stopped major diseases in their tracks. Imagine that just ten years ago a patient might not be alive months or years after a diagnosis, whereas today a simple pill can cure or prevent a deadly disease. See More

  • Do Topical Medications Voltaren, Pennsaid, and Flector Work for Pain?

    April 30, 2015

    Joint pain from arthritis, an injury, or overuse often requires the use of anti-inflammatory medications. Many people hate taking pills by mouth because they can be hard on the stomach and kidneys. But do the topical options work? What are your options and which is the best?

    Non-steroidal anti-inflammatory (NSAID) topical options:

    In the United States, three topical NSAID products are approved to treat pain including Voltaren Gel (diclofenac sodium 1%), Pennsaid topical solution (diclofenac sodium 1. See More

  • Dropped by Insurance? Coverage Improves Instead for Inflammatory Conditions

    September 19, 2014

    A 2014 comes to a close, we should be thinking about what to expect for 2015. The start of a new year is a time for new challenges, new goals, and inevitably, a new prescription formulary.

    What does this mean for you?

    Express Scripts has actually decided to add a medication back to their national preferred formulary. When it comes to drugs that treat inflammatory conditions like arthritis, psoriasis, and ulcerative colitis, you’ll actually have another option this year. See More

  • 40+ Brand-Name Drugs Dropped By Insurance in 2015

    August 20, 2014

    For many Americans with health insurance, more than 40 popular brand-name drugs may no longer be covered starting in January 2015. Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing over 40 drugs from their formularies at the end of 2014. This is in addition to the more than 50 drugs removed last year.

    What are Express Scripts and Caremark?

    Express Scripts and Caremark are companies that administer prescription drug benefits for many health insurance companies and Tricare. See More

  • Generic Celebrex Approved!

    June 03, 2014

    Generic Celebrex (celecoxib) has been approved by the FDA as of May 30, 2014. Teva Pharmaceuticals received exclusive market rights for 180 days on the 100 mg, 200 mg, and 400 mg capsules, while Mylan Pharmaceuticals has also been approved to market the 50 mg capsules.

    When will generic celecoxib be available?

    Mylan Pharmaceuticals plans to begin selling their 50 mg capsule at the earliest point it can, but not later than December 2014. See More

  • Voltaren Gel: Behold the Awesomeness

    November 27, 2013

    Voltaren 1% gel has a huge fan base, rightly so. Voltaren 1% gel (topical diclofenac) works as well as anti-inflammatory pills for hand and knee pain due to arthritis, with way fewer side effects. Let’s get this straight. Yep, results from 34 studies were reviewed and the topical anti-inflammatory Voltaren gel alleviated pain in the hands or knees more often than oral NSAIDS (ibuprofen, advil, naproxen as examples). See More

  • Dropped by Insurance: Will Your Pain Prescriptions Be Covered in 2014?

    November 20, 2013

    Express Scripts and Caremark have removed certain medications from their formulary starting in January 2014. These companies handle prescription benefits for more than 200 million Americans, so your prescription coverage will likely be changing in the new year.

    We’re reviewing which prescriptions will no longer be covered and the suggested alternatives to give you a better picture of your options. Listed below are some changes to the pain med coverage from each formulary that might affect you:

    Caremark

    Removed medication: Flector patches   ||   Suggested Alternative: diclofenac, meloxicam, or naproxen

    The convenient Flector patch will be an excluded medication as of 2014. See More

  • Dropped by Insurance: In 2014, Will Your Arthritis and Transplant Drugs Be Covered?

    November 13, 2013

    Express Scripts and Caremark have removed certain medications from their formulary starting in January 2014. These companies handle prescription benefits for more than 200 million Americans, so your prescription coverage will likely be changing in the new year.

    Over the next couple of weeks, we’ll be reviewing which prescriptions will no longer be covered and the suggested alternatives to give you a better picture of your options. See More

Copyright ©2018 GoodRx, Inc.

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.

In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.

Safe Pharmacy